- Scheme Category:
- Other Scheme >
- Index Funds
NAV: ₹ 21.2339 ↑ 1.25%
[as on 15 April, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth and its peers as on 15 April, 2026
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | 16.96% | -3.92% | 27.42% | 27.77% | 5.49% |
Discrete returns (monthly)
| Month | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 |
|---|
| Returns | 3.55% | 1.64% | 0.28% | -0.2% | 1.42% | 3.83% | -0.71% | -2.51% | 5.16% | -4.55% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 99.85% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
0.15% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.16% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 6.14% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.84% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 5.54% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.32% |
| Dr. Reddy's Laboratories Ltd. | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 4.81% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 3.45% |
| Lupin Ltd. | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 3.08% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 2.90% |
| Laurus Labs Ltd. | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 2.30% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 2.05% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.03% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 1.84% |
| Zydus Lifesciences Ltd. | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 1.69% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 1.59% |
| Biocon Ltd. | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.37% |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.22% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 0.98% |
| Narayana Hrudayalaya ltd. | NH (INE410P01011) | Healthcare Services | 0.86% |
| Piramal Pharma Ltd. | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 0.82% |
| Syngene International Ltd. | SYNGENE (INE398R01022) | Healthcare Services | 0.81% |
| GlaxoSmithKline Pharmaceuticals Ltd. | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 0.76% |
| Ajanta Pharma Ltd. | AJANTPHARM (INE031B01049) | Pharmaceuticals & Biotechnology | 0.74% |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 0.73% |
| Cohance Lifesciences Ltd. | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 0.59% |
| ELI LILLY & CO | US5324571083 | Pharmaceuticals | 5.75% |
| JOHNSON & JOHNSON | US4781601046 | Pharmaceuticals | 3.75% |
| ABBVIE INC | US00287Y1091 | Biotechnology | 3.18% |
| NOVARTIS AG | US66987V1098 | Pharmaceuticals | 1.94% |
| MERCK & CO.INC | US58933Y1055 | Pharmaceuticals | 1.78% |
| ABBOTT LABORATORIES | US0028241000 | Health Care Equipment & Supplies | 1.78% |
| THERMO FISHER SCIENTIFIC INC | US8835561023 | Life Sciences Tools & Services | 1.77% |
| INTUITIVE SURGICAL INC | US46120E6023 | Health Care Equipment & Supplies | 1.58% |
| AMGEN INC | US0311621009 | Biotechnology | 1.33% |
| Novo Nordisk A/S | US6701002056 | Pharmaceuticals & Biotechnology | 1.31% |
| GILEAD SCIENCES INC | US3755581036 | Biotechnology | 1.23% |
| DANAHER CORP | US2358511028 | Health Care Equipment & Supplies | 1.15% |
| STRYKER CORP | US8636671013 | Health Care Equipment & Supplies | 1.01% |
| MEDTRONIC PLC | IE00BTN1Y115 | Health Care Equipment & Supplies | 0.96% |
| VERTEX PHARMACEUTICALS INC | US92532F1003 | Biotechnology | 0.90% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | Pharmaceuticals | 0.58% |
| BECTON DICKINSON AND CO | US0758871091 | Health Care Equipment & Supplies | 0.42% |
| AGILENT TECHNOLOGIES INC | US00846U1016 | Life Sciences Tools & Services | 0.34% |
| IQVIA HOLDINGS INC | US46266C1053 | Life Sciences Tools & Services | 0.31% |
| ILLUMINA INC | US4523271090 | Life Sciences Tools & Services | 0.16% |
Portfolio data is as on date 31 October, 2025
NAV history
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|
| 15 April, 2026 | 21.2339 | 1.25% |
| 13 April, 2026 | 20.9709 | 0.12% |
| 10 April, 2026 | 20.9461 | -0.27% |
| 9 April, 2026 | 21.0034 | 0.55% |
| 8 April, 2026 | 20.8877 | 0.94% |
| 7 April, 2026 | 20.6922 | 0.01% |
| 6 April, 2026 | 20.6897 | -0.04% |
| 2 April, 2026 | 20.6976 | -1.42% |
| 1 April, 2026 | 20.9957 | -0.43% |
| 31 March, 2026 | 21.0864 | 0.61% |
| 30 March, 2026 | 20.9592 | -0.87% |
| 27 March, 2026 | 21.1432 | -0.74% |
| 25 March, 2026 | 21.3008 | 1.79% |
| 24 March, 2026 | 20.9259 | 0.73% |
| 23 March, 2026 | 20.7737 | -1.18% |
| 20 March, 2026 | 21.0227 | 1.23% |
| 19 March, 2026 | 20.7675 | -1.88% |
| 18 March, 2026 | 21.1651 | -0.4% |
| 17 March, 2026 | 21.2511 | -0.18% |
| 16 March, 2026 | 21.29 | -0.75% |
| 13 March, 2026 | 21.4517 | -1.41% |
| 12 March, 2026 | 21.7586 | -0.78% |
| 11 March, 2026 | 21.9298 | -0.06% |
| 10 March, 2026 | 21.9429 | 0.56% |
| 9 March, 2026 | 21.8209 | 0.45% |
| 6 March, 2026 | 21.7235 | -0.43% |
| 5 March, 2026 | 21.8177 | 0.1% |
| 4 March, 2026 | 21.796 | -1.01% |
| 2 March, 2026 | 22.0193 | -0.32% |
| 27 February, 2026 | 22.0909 | |
FAQ (Frequently asked questions)
What is latest/current NAV/price of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The latest NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth is 21.2339 as on 15 April, 2026.
What are YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The YTD (year to date) returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are -0.93% as on 15 April, 2026.
What are 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 1 year returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 11.99% as on 15 April, 2026.
What are 3 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 3 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 19.62% as on 15 April, 2026.
What are 5 year CAGR returns of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The 5 year annualized returns (CAGR) of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth are 12.96% as on 15 April, 2026.
